Peptide AOD 9604 is a modified form of amino acids 176-191 and was originally used as an anti-obesity drug
It is not for human use, injection, consumption, veterinary applications or any medical purposes
No impact on bone fractures : If osteoporosis is a concern, the GLP-1 receptor agonists were shown not to increase fracture rates.[ref] Benefits for CVD : In a huge cardiovascular disease study, GLP-1 RAs were shown to be associated with a lower risk of heart attacks and strokes.[ref] Works best with Exercise: A randomized clinical trial found that GLP-1 RAs work best for weight loss when combined with exercise
This makes it valuable for medication makers and research institutes seeking holistic inflammatory treatments
The available abstract does not provide the detail expected from a modern confirmatory ophthalmology trial, including clear randomisation, masking, comparator treatment, complete adverse-event reporting and independently verified outcomes
It is critical to evaluate the benefits and hazards with your healthcare professional, such as Dr